BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cheung KS, Leung WK. Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management. World J Gastroenterol 2017; 23(11): 1954-1963 [PMID: 28373761 DOI: 10.3748/wjg.v23.i11.1954]
URL: https://www.wjgnet.com/1007-9327/full/v23/i11/1954.htm
Number Citing Articles
1
Annie M. Young, Andrea Marshall, Jenny Thirlwall, Oliver Chapman, Anand Lokare, Catherine Hill, Danielle Hale, Janet A. Dunn, Gary H. Lyman, Charles Hutchinson, Peter MacCallum, Ajay Kakkar, F.D. Richard Hobbs, Stavros Petrou, Jeremy Dale, Christopher J. Poole, Anthony Maraveyas, Mark Levine. Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)Journal of Clinical Oncology 2018; 36(20): 2017 doi: 10.1200/JCO.2018.78.8034
2
Kristína Grilusová, Tomáš Bolek, Ingrid Škorňová, Lucia Stančiaková, Veronika Mikušová, Peter Kubisz, Peter Galajda, Ján Staško, Matej Samoš, Marián Mokáň. Apixaban: An Optimal Agent for the Treatment of Cancer-Associated Venous Thromboembolism?American Journal of Therapeutics 2022; 29(2): e212 doi: 10.1097/MJT.0000000000001451
3
Olga D. Ostroumova, Aleksey I. Kochetkov, Svetlana V. Batyukina, Sergey V. Cheremushkin. Gastroprotective therapy in patients with atrial fibrillation receiving anticoagulant therapy: A reviewConsilium Medicum 2023; 25(5): 368 doi: 10.26442/20751753.2023.5.202294
4
Juan Pablo Salazar Adum, Iva Golemi, Luis H. Paz, Luis Diaz Quintero, Alfonso J. Tafur, Joseph A. Caprini. Venous thromboembolism controversiesDisease-a-Month 2018; 64(9): 408 doi: 10.1016/j.disamonth.2018.03.003
5
Mei-na Lv, Xiao-chun Zheng, Hong-qin Zhang, Fang-da Xu, Ting-ting Wu, Wen-jun Chen, Xiao-tong Xia, Jing-lan Fu, Shao-jun Jiang, Jin-hua Zhang. Comparison of clinical performance of four gastrointestinal bleeding risk scores in Chinese patients with atrial fibrillation receiving oral anticoagulantsJournal of Thrombosis and Thrombolysis 2021; 51(1): 136 doi: 10.1007/s11239-020-02152-1
6
Diego F. Rodríguez, Francisca Durán-Osorio, Yorley Duarte, Pedro Olivares, Yanina Moglie, Kamal Dua, Flavia C. Zacconi. Green by Design: Convergent Synthesis, Computational Analyses, and Activity Evaluation of New FXa Inhibitors Bearing Peptide Triazole Linking UnitsPharmaceutics 2021; 14(1): 33 doi: 10.3390/pharmaceutics14010033
7
Fang Jiang, Chengsheng Ju, Chuan‐Guo Guo, Ka Shing Cheung, Bofei Li, Simon Y. K. Law, Wallis C. Y. Lau, Wai K. Leung. Risk of hospitalization for upper gastrointestinal bleeding in Helicobacter pylori eradicated patients newly started on warfarin or direct oral anticoagulants: A population‐based cohort studyHelicobacter 2023; 28(4) doi: 10.1111/hel.12990
8
Taishi HATA. Venous thromboembolism (VTE) in gastrointestinal cancer treatmentJapanese Journal of Thrombosis and Hemostasis 2023; 34(5): 584 doi: 10.2491/jjsth.34.584
9
森山 直紀 (Naoki Moriyama), 当麻 美樹 (Yoshiki Tohma), 川嶋 太郎 (Taro Kawashima), 國重 千佳 (Chika Kunishige), 小野 雄一郎 (Yuichiro Ono), 高橋 晃 (Akira Takahashi), 佐野 秀 (Shigeru Sano). ダビガトラン内服中に生じた広範囲結腸粘膜下出血により結腸亜全摘を余儀なくされた1例(A case of subtotal colectomy caused by dabigatran–associated extensive intramural hemorrhage of the colon)Nihon Kyukyu Igakukai Zasshi: Journal of Japanese Association for Acute Medicine 2019; 30(5): 146 doi: 10.1002/jja2.12363
10
Andrea Pozzi, Fabiana Lucà, Sandro Gelsomino, Maurizio Giuseppe Abrignani, Simona Giubilato, Stefania Angela Di Fusco, Carmelo Massimiliano Rao, Stefano Cornara, Giorgio Caretta, Roberto Ceravolo, Iris Parrini, Giovanna Geraci, Carmine Riccio, Massimo Grimaldi, Furio Colivicchi, Fabrizio Oliva, Michele Massimo Gulizia. Coagulation Tests and Reversal Agents in Patients Treated with Oral Anticoagulants: The Challenging Scenarios of Life-Threatening Bleeding and Unplanned Invasive ProceduresJournal of Clinical Medicine 2024; 13(9): 2451 doi: 10.3390/jcm13092451
11
Steven Deitelzweig, Allison Keshishian, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Neeraja Balachander, Lisa Rosenblatt, Jack Mardekian, Jenny Jiang, Huseyin Yuce, Gregory Y. H. Lip. Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patientsTherapeutic Advances in Gastroenterology 2021; 14 doi: 10.1177/1756284821997352
12
Massimiliano Camilli, Marco Lombardi, Giovanni Maria Vescovo, Marco Giuseppe Del Buono, Mattia Galli, Nadia Aspromonte, Giuseppe Biondi Zoccai, Giampaolo Niccoli, Rocco A. Montone, Filippo Crea, Giorgio Minotti. Efficacy and safety of novel oral anticoagulants versus low molecular weight heparin in cancer patients with venous thromboembolism: A systematic review and meta-analysisCritical Reviews in Oncology/Hematology 2020; 154: 103074 doi: 10.1016/j.critrevonc.2020.103074
13
A. P. Pereverzev, O. D. Ostroumova, O. N. Tkacheva, Yu. V. Kotovskaya. Complications of Pharmacotherapy with New Oral Anticoagulants Caused by Inter-Drug Interactions: Focus on Gastrointestinal BleedingSafety and Risk of Pharmacotherapy 2019; 7(2): 65 doi: 10.30895/2312-7821-2019-7-2-65-71
14
O. D. Ostroumova, E. A. Volkova, A. I. Kochetkov, A. P. Pereverzev, O. N. Tkacheva. Prevention of gastrointestinal bleeding in patients receiving oral anticoagulants: focus on proton pump inhibitorsCardiovascular Therapy and Prevention 2019; 18(5): 128 doi: 10.15829/1728-8800-2019-5-128-137
15
Doris Barcellona, L. Fenu, F. Marongiu. Clinical history and gastrointestinal bleeding in patients taking oral anticoagulantsInternational Journal of Cardiology 2021; 339: 134 doi: 10.1016/j.ijcard.2021.07.029
16
Arnar B. Ingason, Johann P. Hreinsson, Arnar S. Agustsson, Sigrun H. Lund, Edward Rumba, Daniel A. Palsson, Indridi E. Reynisson, Brynja R. Gudmundsdottir, Pall T. Onundarson, Einar S. Bjornsson. Warfarin Is Associated With Higher Rates of Upper But Not Lower Gastrointestinal Bleeding Compared with Direct Oral Anticoagulants: A Population-Based Propensity-Weighted Cohort StudyClinical Gastroenterology and Hepatology 2023; 21(2): 347 doi: 10.1016/j.cgh.2022.06.033
17
Jang Ho Lee, Dalsan You, Sang-Do Lee, Yeon-Mok Oh, Jae Seung Lee. A Study on the Efficacy and Safety of Rivaroxaban in Urologic Cancer-Associated Venous ThromboembolismThe Korean Journal of Urological Oncology 2019; 17(3): 178 doi: 10.22465/kjuo.2019.17.3.178
18
Mostafa El Mokadem, Ahmed Hassan, Abdulaziz Z Algaby. Efficacy and safety of apixaban in patients with active malignancy and acute deep venous thrombosisVascular 2021; 29(5): 745 doi: 10.1177/1708538120971148
19
Takatsugu Yamamoto, Yuji Mizokami, Takeshi Yamashita, Masaharu Akao, Hirotsugu Atarashi, Takanori Ikeda, Yukihiro Koretsune, Ken Okumura, Wataru Shimizu, Shinya Suzuki, Hiroyuki Tsutsui, Kazunori Toyoda, Atsushi Hirayama, Masahiro Yasaka, Takenori Yamaguchi, Satoshi Teramukai, Tetsuya Kimura, Yoshiyuki Morishima, Atsushi Takita, Hiroshi Inoue. Gastrointestinal bleeding in elderly patients with atrial fibrillation: prespecified All Nippon Atrial Fibrillation in the Elderly (ANAFIE) Registry subgroup analysisScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-59932-5
20
Ritika Halder, Eric Brucks, Ce Cheng, Kathylynn Saboda, Hani M. Babiker, Ali Mcbride, Alejandro Recio-Boiles. Retrospective real-world meta-analysis of high-risk major bleeding as a primary safety outcome in cancer patients receiving therapeutic anticoagulationThrombosis Update 2022; 9: 100121 doi: 10.1016/j.tru.2022.100121
21
Gilles Lemesle, Christophe Bauters, Laurent Bonello, Laurent Fauchier, Guillaume Cayla, Eloi Marijon, Maxime Guenoun, Guillaume Schurtz, Sandro Ninni, Marjorie Richardson, Franck Albert, Serge Cohen, Nicolas Lamblin, Nicolas Danchin. Management of antithrombotics in situations with a gap in evidence: A national French survey focusing on patients with coronary artery disease and atrial fibrillationInternational Journal of Cardiology 2022; 348: 15 doi: 10.1016/j.ijcard.2021.11.077
22
Chun En Yau, Chen Ee Low, Natasha Yixuan Ong, Sounak Rana, Lucas Jun Rong Chew, Sara Moiz Tyebally, Ping Chai, Tiong-Cheng Yeo, Mark Y. Chan, Matilda Xinwei Lee, Li-Ling Tan, Chieh-Yang Koo, Ainsley Ryan Yan Bin Lee, Ching-Hui Sia. Non-Vitamin K Antagonist Oral Anticoagulants versus Low Molecular Weight Heparin for Cancer-Related Venous Thromboembolic Events: Individual Patient Data Meta-AnalysisCancers 2023; 15(24): 5887 doi: 10.3390/cancers15245887
23
Sung Hee Youn, Hyun Lim, Yeonmi Ju, Jae Seung Soh, Ji Won Park, Ho Suk Kang, Sung Eun Kim, Sung Hoon Moon, Jong Hyeok Kim, Choong Kee Park, Seung In Seo, Woon Geon Shin. Effect of gastroprotective agents on upper gastrointestinal bleeding in patients receiving direct oral anticoagulantsScandinavian Journal of Gastroenterology 2018; 53(12): 1490 doi: 10.1080/00365521.2018.1541478
24
Jang Ho Lee, Joo Hee Lee, Kyung-Wook Jo, Jin-Won Huh, Yeon-Mok Oh, Jae Seung Lee. Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancersJournal of Gynecologic Oncology 2020; 31(1) doi: 10.3802/jgo.2020.31.e10
25
Rohan Stuart Smith, Stephanie Wei Jia Tan, Genevieve Ann Heath‐Kalgutkar, Vu Hoang Tran, Ashray Rajagopalan, Tim Buckenham. Factors predicting positive CT mesenteric angiography results in lower gastrointestinal haemorrhage prior to consideration of intra‐arterial angio‐embolisationJournal of Medical Imaging and Radiation Oncology 2021; 65(7): 841 doi: 10.1111/1754-9485.13176
26
Siyu Yang, Ye Xu, Yang Zhang, Dandan Li, Xingang Li. Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysisCurrent Pharmaceutical Design 2024; 30(15): 1167 doi: 10.2174/0113816128293940240315073345
27
Tadakiyo Ido, Shun Sasaki, Yohei Sotomi, Akio Hirata, Nobuhiko Makino, Takaharu Hayashi, Yasushi Sakata, Atsushi Hirayama, Yoshiharu Higuchi. Twice- or once-daily dosing of direct oral anticoagulants and gastrointestinal bleeding in patient with atrial fibrillationAmerican Heart Journal Plus: Cardiology Research and Practice 2022; 22: 100203 doi: 10.1016/j.ahjo.2022.100203
28
Hanno Riess, Peter Verhamme, Jeffrey I. Weitz, Annie Young, Rupert Bauersachs, Jan Beyer-Westendorf, Mark Crowther, Anthony Maraveyas. Treatment of cancer-associated thrombosis: The evolution of anticoagulant choice and clinical insights into practical managementCritical Reviews in Oncology/Hematology 2021; 157: 103125 doi: 10.1016/j.critrevonc.2020.103125
29
Kathlyne Jayne B. Bautista, Jinwook Kim, Zhen Xu, Xiaoning Jiang, Paul A. Dayton. Current Status of Sub-micron Cavitation-Enhancing Agents for SonothrombolysisUltrasound in Medicine & Biology 2023; 49(5): 1049 doi: 10.1016/j.ultrasmedbio.2023.01.018
30
Maurizio Giuseppe Abrignani, Alberto Lombardo, Annabella Braschi, Nicolò Renda, Vincenzo Abrignani. Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of viewWorld Journal of Cardiology 2023; 15(8): 375-394 doi: 10.4330/wjc.v15.i8.375
31
M. Hennessy, B. Reidy, F. Ní Ainle, J. Conneely, C. McDermott, P. Ó. Scanaill. Supratherapeutic dabigatran: a cause of life‐threatening haemorrhage*Anaesthesia Reports 2023; 11(1) doi: 10.1002/anr3.12208
32
E. I. Baranova, V. A. Ionin, A. A. Katsap, O. S. Kolesnik, E. V. Lebedeva. Safety of direct oral anticoagulants in patients with atrial fibrillation and high risk of stroke (review of literature)The Scientific Notes of the Pavlov University 2020; 26(3): 43 doi: 10.24884/1607-4181-2019-26-3-43-56
33
Rosa Purgatorio, Nicola Gambacorta, Francesco Samarelli, Gianfranco Lopopolo, Modesto de Candia, Marco Catto, Orazio Nicolotti, Cosimo D. Altomare. Assessing the Role of a Malonamide Linker in the Design of Potent Dual Inhibitors of Factor Xa and CholinesterasesMolecules 2022; 27(13): 4269 doi: 10.3390/molecules27134269
34
Ibrahim Halil Inanc, Saadet Kılıc, Murat Polat. Rivaroxaban induced spontaneous hemoperitoneum around terminal ileum and cecum clinically mimicking acute appendicitis in a young patient: First case reportJournal of Clinical Medicine of Kazakhstan 2020; 2(56): 50 doi: 10.23950/1812-2892-JCMK-00756
35
Tomonari Shimoda, Atsuyuki Watanabe. Apixaban for Atrial Fibrillation and Systemic Fluconazole: Bleeding Risk and Possible Preventative MeasuresThe American Journal of Medicine 2022; 135(10): e406 doi: 10.1016/j.amjmed.2022.05.023
36
Anders Holt, Paul Blanche, Bochra Zareini, Peter Vibe Rasmussen, Jarl Emanuel Strange, Deepthi Rajan, Mads Hashiba Jensen, Mohammed El-Sheikh, Anne-Marie Schjerning, Morten Schou, Gunnar Gislason, Christian Torp-Pedersen, Patricia McGettigan, Morten Lamberts. Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulantsHeart 2022; 108(8): 626 doi: 10.1136/heartjnl-2021-319503
37
J. Starup-Linde, B. Langdahl, P. Vestergaard, T. Harsløf. Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort studyOsteoporosis International 2022; 33(6): 1323 doi: 10.1007/s00198-022-06315-z
38
Laura M Attard, Alex Gatt, Laurent Bertoletti, Aurelien Delluc, Nicoletta Riva. Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated ThrombosisVascular Health and Risk Management 2022; : 793 doi: 10.2147/VHRM.S271411
39
Gregory Y. H. Lip, Robert Benamouzig, Anne-Céline Martin, Giancarlo Pesce, Gaelle Gusto, Nadia Quignot, Artak Khachatryan, Feng Dai, Fouad Sedjelmaci, Jose Chaves, Rupesh Subash, Ruth Mokgokong, Xinlin Zhang. Comparative safety and effectiveness of oral anticoagulants in patients with non-valvular atrial fibrillation and high risk of gastrointestinal bleeding: A nationwide French cohort studyPLOS ONE 2024; 19(11): e0310322 doi: 10.1371/journal.pone.0310322
40
Ken Ohata, Eiji Sakai, Yuichiro Suzuki, Shunya Takayanagi, Marie Kurebayashi, Yoshiaki Kimoto, Rindo Ishii, Takafumi Konishi, Kohei Ono, Tomoya Hirata, Keisuke Kanda, Maiko Takita, Ryoju Negishi, Yohei Minato, Takashi Muramoto, Hitoshi Satodate, Masataka Taguri, Nobuyuki Matsuhashi. Risk factors of delayed bleeding after endoscopic resection of superficial non‐ampullary duodenal epithelial tumors and prevention by over‐the‐scope and conventional clippingDigestive Endoscopy 2021; 33(3): 390 doi: 10.1111/den.13729
41
Daniel Wadsworth, Emma Sullivan, Thomas Jacky, Taylor Sprague, Hannah Feinman, Jennifer Kim. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulantJournal of Clinical Pharmacy and Therapeutics 2021; 46(3): 560 doi: 10.1111/jcpt.13343
42
Qian Xiang, Zhe Wang, Guangyan Mu, Qiufen Xie, Zhiyan Liu, Shuang Zhou, Hanxu Zhang, Zining Wang, Jie Jiang, Kun Hu, Yatong Zhang, Zinan Zhao, Dongdong Yuan, Liping Guo, Tingting Wu, Jinhua Zhang, Na Wang, Jing Xiang, Zhichun Gu, Jianjun Sun, Yimin Cui. Genetic variants influenced the risk of bleeding and pharmacodynamics of rivaroxaban in patients with nonvalvular atrial fibrillation: A multicentre prospective cohort studyClinical and Translational Medicine 2023; 13(5) doi: 10.1002/ctm2.1263
43
Ruchi Desai, Gautam Krishna Koipallil, Nelson Thomas, Rahul Mhaskar, Nathan Visweshwar, Damian Laber, Ankita Patel, Michael Jaglal. Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trialsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75863-3
44
Luiz Gonzaga Vaz COELHO, James Ramalho MARINHO, Robert GENTA, Laercio Tenório RIBEIRO, Maria do Carmo Friche PASSOS, Schlioma ZATERKA, Paulo Pimentel ASSUMPÇÃO, Alfredo José A BARBOSA, Ricardo BARBUTI, Lucia Libanês BRAGA, Helenice BREYER, Aloisio CARVALHAES, Décio CHINZON, Marcelo CURY, Gerson DOMINGUES, Jorge Luiz JORGE, Ismael MAGUILNIK, Frederico Passos MARINHO, Joaquim Prado de MORAES-FILHO, José Miguel Luz PARENTE, Celso Mirra de PAULA-E-SILVA, José PEDRAZZOLI-JÚNIOR, Ana Flávia Passos RAMOS, Heinrich SEIDLER, José Nonato SPINELLI, José Vitor ZIR. IVTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTIONArquivos de Gastroenterologia 2018; 55(2): 97 doi: 10.1590/s0004-2803.201800000-20
45
Dan Zhang, Wei Qin, Wenwen Du, Xiaoxing Wang, Wenqian Chen, Pengmei Li. Effect of ABCB1 gene variants on rivaroxaban pharmacokinetic and hemorrhage events occurring in patients with non‐valvular atrial fibrillationBiopharmaceutics & Drug Disposition 2022; 43(4): 163 doi: 10.1002/bdd.2327
46
Arnar B. Ingason, Johann P. Hreinsson, Einar S. Björnsson. Gastrointestinal Bleeding on Oral Anticoagulation: What is Currently KnownDrug Safety 2022; 45(12): 1449 doi: 10.1007/s40264-022-01243-7
47
N. M. Vorobyeva, O. N. Tkacheva. Value of Safety of Anticoagulant Therapy in Elderly Patient with Atrial Fibrillation and High Risk of BleedingRational Pharmacotherapy in Cardiology 2023; 19(1): 101 doi: 10.20996/1819-6446-2023-01-02
48
Hyung Hwan Moon. Refractory Ascites with Intrahepatic Portal Thrombosis after Living Donor Liver Transplantation Successfully Treated by Splenic Artery Embolization and Apixaban (Case Report)Kosin Medical Journal 2021; 36(2): 187 doi: 10.7180/kmj.2021.36.2.187
49
Wenlin Hao, Anlei Liu, Huadong Zhu, Xuezhong Yu, Gang Chen, Jun Xu. Risk factors and management of gastrointestinal bleeding in patients with or without antiplatelet and anticoagulation therapy: a multicenter real-world prospective studyBMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03238-3
50
Lubomir Mihalkanin, Branislav Stancak. The Impact of Novel Anticoagulants on the Upper Gastrointestinal Tract MucosaMedicina 2020; 56(7): 363 doi: 10.3390/medicina56070363
51
Ju Yup Lee. Risk Factors of Gastrointestinal Bleeding in Patients Receiving New Oral AnticoagulantsThe Korean Journal of Helicobacter and Upper Gastrointestinal Research 2018; 18(4): 219 doi: 10.7704/kjhugr.2018.18.4.219
52
Jakub Z. Qazi, Mireille E. Schnitzer, Robert Côté, Marie-Josée Martel, Marc Dorais, Sylvie Perreault, Gianluigi Savarese. Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after dischargePLOS ONE 2021; 16(3): e0246691 doi: 10.1371/journal.pone.0246691
53
Ya-Ling Huang, Ching-Yao Chen, Ching-Chi Chu. Risk of major bleeding and thromboembolism in Asian patients with nonvalvular atrial fibrillation using direct oral anticoagulants versus warfarinInternational Journal of Clinical Pharmacy 2022; 44(1): 34 doi: 10.1007/s11096-021-01309-z
54
Jae Myung Cha, Myoungsuk Kim, Hyeong Ho Jo, Won-Woo Seo, Sang Youl Rhee, Ji Hyun Kim, Gwang Ha Kim, Junseok Park. Real-World Risk of Gastrointestinal Bleeding for Direct Oral Anticoagulants and Warfarin Users: A Distributed Network Analysis Using a Common Data ModelGut and Liver 2024; 18(5): 814 doi: 10.5009/gnl230406
55
Parita Patel, Neil Sengupta. PPIs and Beyond: A Framework for Managing Anticoagulation-Related Gastrointestinal Bleeding in the Era of COVID-19Digestive Diseases and Sciences 2020; 65(8): 2181 doi: 10.1007/s10620-020-06408-x
56
Sreeram V Ramagopalan, Mihail Samnaliev, Sharada Weir, Cormac J Sammon, Robert Carroll, Raza Alikhan. Costs of Gastrointestinal Bleeding Events in Atrial Fibrillation: A Uk Clinical Practice Research Datalink StudyFuture Cardiology 2019; 15(5): 367 doi: 10.2217/fca-2019-0033
57
N. V. Bakulina, S. V. Tikhonov, N. B. Lishchuk, A. B. Karaya. Management of risk factors for gastrointestinal bleeding in patients receiving anticoagulant therapyRussian Journal of Cardiology 2021; 26(8): 4635 doi: 10.15829/1560-4071-2021-4635
58
Charles J. Ferro, Fay Solkhon, Zahraa Jalal, Abdullah M. Al‐Hamid, Alan M. Jones. Relevance of physicochemical properties and functional pharmacology data to predict the clinical safety profile of direct oral anticoagulantsPharmacology Research & Perspectives 2020; 8(3) doi: 10.1002/prp2.603
59
Ivan David Lozada Martinez, Luis Carlos Solano Díaz, Marcela Barbosa Pérez, Víctor Andrés Rueda Oviedo, Brainerd Lenin Caicedo Moncada, Gustavo Andrés Diaz Cruz, Adriana cristina Ceballos Espitia, David Esteban Diaz Gómez, Daiana Andrea Rojas Ramírez . Riesgo de sangrado gastrointestinal por uso de anticoagulantes directos orales: ¿cuál es más seguro?Revista Cuarzo 2022; 28(2): 31 doi: 10.26752/cuarzo.v28.n2.656
60
Meghdad Sedaghat, Behnam Safarpour Lima, Reihanesadat Bouzari, Sarvenaz Shadlou. Gastrointestinal Bleeding Associated With Warfarin and Rivaroxaban Therapy in Atrial Fibrillation Cases with Concomitant CoagulopathyCardiovascular & Hematological Disorders-Drug Targets 2021; 21(2): 123 doi: 10.2174/1871529X20999201231210044
61
Gregory Y. H. Lip, Allison V. Keshishian, Yan Zhang, Amiee Kang, Amol D. Dhamane, Xuemei Luo, Christian Klem, Mauricio Ferri, Jenny Jiang, Huseyin Yuce, Steven Deitelzweig. Oral Anticoagulants for Nonvalvular Atrial Fibrillation in Patients With High Risk of Gastrointestinal BleedingJAMA Network Open 2021; 4(8): e2120064 doi: 10.1001/jamanetworkopen.2021.20064
62
Vítor Macedo Silva, Marta Freitas, Cátia Arieira, Sofia Xavier, Pedro Boal Carvalho, Bruno Rosa, Maria João Moreira, José Cotter. Direct oral anticoagulants are associated with potentially bleeding lesions in suspected mid-gastrointestinal bleedingScandinavian Journal of Gastroenterology 2022; 57(4): 486 doi: 10.1080/00365521.2021.2014951
63
Veronica Ojetti, Angela Saviano, Mattia Brigida, Luisa Saviano, Alessio Migneco, Francesco Franceschi. A Review on the Use of Reversal Agents of Direct Oral Anticogulant Drugs in Case of Gastrointestinal BleedingReviews on Recent Clinical Trials 2021; 15(4): 309 doi: 10.2174/1574887115666200624193938
64
Stefano Ballestri, Elisa Romagnoli, Dimitriy Arioli, Valeria Coluccio, Alessandra Marrazzo, Afroditi Athanasiou, Maria Di Girolamo, Cinzia Cappi, Marco Marietta, Mariano Capitelli. Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: a Narrative ReviewAdvances in Therapy 2023; 40(1): 41 doi: 10.1007/s12325-022-02333-9
65
Vladimir V. Yurukov, Tracy Boykin, Megan A. Rech. Tranexamic Acid for the Treatment of Acute Gastrointestinal Bleeding in a Jehovah's Witness Patient on Apixaban and Dual Antiplatelet TherapyAdvanced Emergency Nursing Journal 2022; 44(1): 11 doi: 10.1097/TME.0000000000000386
66
Xinkang Wang, Qiu Li, Fuyong Du, Neetu Shukla, Andrea R. Nawrocki, Madhu Chintala. Antithrombotic Effects of the Novel Small-Molecule Factor XIa Inhibitor Milvexian in a Rabbit Arteriovenous Shunt Model of Venous ThrombosisTH Open 2023; 7(02): e97 doi: 10.1055/a-2061-3311
67
Yu Jia, Shao-Hua Wang, Na-Juan Cui, Quan-Xi Liu, Wei Wang, Xue Li, Ya-Mei Gu, Yan Zhu. Idarucizumab reverses dabigatran-induced anticoagulation in treatment of gastric bleeding: A case reportWorld Journal of Clinical Cases 2022; 10(8): 2537-2542 doi: 10.12998/wjcc.v10.i8.2537
68
Kaori Ambe, Ayu Akita, Jie Wei, Yuka Yoshii, Mayu Onishi, Masahiro Tohkin. Comparison of Efficacy and Safety of Direct Oral Anticoagulants and Warfarin between Patients in Asian and Non‐Asian Regions: A Systematic Review and Meta‐Regression AnalysisClinical Pharmacology & Therapeutics 2023; 113(6): 1240 doi: 10.1002/cpt.2881
69
So-Ryoung Lee, Soonil Kwon, Eue-Keun Choi, Jin-Hyung Jung, Kyung-Do Han, Seil Oh, Gregory Y. H. Lip. Proton Pump Inhibitor Co-Therapy in Patients with Atrial Fibrillation Treated with Oral Anticoagulants and a Prior History of Upper Gastrointestinal Tract BleedingCardiovascular Drugs and Therapy 2022; 36(4): 679 doi: 10.1007/s10557-021-07170-6
70
Melina Verso, Michela Giustozzi, Alessandra Vinci, Laura Franco, Maria Cristina Vedovati, Emanuela Marchesini, Cecilia Becattini, Giancarlo Agnelli. Risk factors and one-year mortality in patients with direct oral anticoagulant-associated gastrointestinal bleedingThrombosis Research 2021; 208: 138 doi: 10.1016/j.thromres.2021.10.022
71
Giulio Francesco Romiti, Bernadette Corica, Marco Proietti. A Comprehensive Appraisal of Dabigatran Etexilate Clinical Evidence and Applications: A 10-year-long StoryFuture Cardiology 2021; 17(2): 215 doi: 10.2217/fca-2020-0084
72
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, F. N. Muradova, L. Y. Koroleva. Gastrointestinal Bleeding in Antithrombotic Therapy in Patients with Coronary Heart Disease: Risk Factors, Pathogenesis and TreatmentRussian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(3): 14 doi: 10.22416/1382-4376-2020-30-3-14-23
73
Yi Ren, Shi-Liang Cao, Zeng Li, Tim Luo, Bin Feng, Xi-Sheng Weng. Comparable efficacy of 100 mg aspirin twice daily and rivaroxaban for venous thromboembolism prophylaxis following primary total hip arthroplasty: a randomized controlled trialChinese Medical Journal 2021; 134(2): 164 doi: 10.1097/CM9.0000000000001305
74
Xiaoli Wang, Shuo Wang, Michael A. Morse, Ni Jiang, Yanjie Zhao, Yuguang Song, Lei Zhou, Hongyan Huang, Xinna Zhou, Amy Hobeika, Jun Ren, Herbert Kim Lyerly. Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patientsJournal of Thrombosis and Thrombolysis 2019; 47(4): 505 doi: 10.1007/s11239-019-01844-7
75
Ryan Dunn, Nishant Sahni. 62-Year-Old Man With Abdominal PainMayo Clinic Proceedings 2023; 98(2): 337 doi: 10.1016/j.mayocp.2022.06.033
76
Rachel Ryu, Rebecca Tran. DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review of Emerging Data and Future DirectionsClinical and Applied Thrombosis/Hemostasis 2022; 28 doi: 10.1177/10760296221103578
77
Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Euijae Lee, Jin-Hyung Jung, Kyung-Do Han, Myung-Jin Cha, Seil Oh, Gregory Y.H. Lip. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Prior Gastrointestinal BleedingStroke 2021; 52(2): 511 doi: 10.1161/STROKEAHA.120.030761
78
Judith Catella, Laurent Bertoletti, Farès Moustafa, José Antonio Nieto, Reina Valle, José María Pedrajas, Aurora Villalobos, Isabelle Quere, Gabrielle Sarlon-Bartoli, Manuel Monreal. Major gastrointestinal bleeding in patients receiving anticoagulant therapy for venous thromboembolismThrombosis Research 2022; 214: 29 doi: 10.1016/j.thromres.2022.04.005
79
Ka-Shing Cheung, Wai K Leung, Wai-Kay Seto. Application of Big Data analysis in gastrointestinal researchWorld Journal of Gastroenterology 2019; 25(24): 2990-3008 doi: 10.3748/wjg.v25.i24.2990
80
Meixiang Yu, Zi Wang, Liuliu Zong, Qing Xu, Xiaoye Li, Qianzhou Lv. A retrospective cohort study of the effectiveness and safety of dabigatran versus rivaroxaban in overweight patients with nonvalvular atrial fibrillationInternational Journal of Clinical Pharmacy 2022; 44(5): 1149 doi: 10.1007/s11096-022-01443-2
81
Xiangji Dang, Zhilong Liu, Xiaoyun Sheng, Yan Liu. Apply Anticoagulants after Discharge not Benefit to the Incidence of Symptomatic Thrombus in High‐Altitude Areas: A Retrospective StudyOrthopaedic Surgery 2023; 15(12): 3118 doi: 10.1111/os.13888
82
Maurizio Giuseppe Abrignani, Luigi Gatta, Domenico Gabrielli, Giuseppe Milazzo, Vincenzo De Francesco, Leonardo De Luca, Maura Francese, Massimo Imazio, Elisabetta Riccio, Roberta Rossini, Fortunato Scotto di Uccio, Marco Soncini, Angelo Zullo, Furio Colivicchi, Andrea Di Lenarda, Michele Massimo Gulizia, Fabio Monica. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO)European Journal of Internal Medicine 2021; 85: 1 doi: 10.1016/j.ejim.2020.11.014
83
Andrew N. Fleischman, William T. Li, Andrew J. Luzzi, Duncan S. Van Nest, Marc C. Torjman, Eric S. Schwenk, William A. Arnold, Javad Parvizi. Risk of Gastrointestinal Bleeding With Extended Use of Nonsteroidal Anti-Inflammatory Drug Analgesia After Joint ArthroplastyThe Journal of Arthroplasty 2021; 36(6): 1921 doi: 10.1016/j.arth.2021.02.015
84
Meina Lv, Shaojun Jiang, Tingting Wu, Nianxu Huang, Xia Chen, Chunmei Chen, Jinhua Zhang. A new model to predict the risk of major gastrointestinal bleeding in patients on direct oral anticoagulants (dabigatran and rivaroxaban)British Journal of Clinical Pharmacology 2023; 89(1): 253 doi: 10.1111/bcp.15491
85
Pranjal Kumar Singh, T.S. Easwari. Emerging Trends and their Impacts on Peptic Ulcer Diseases: Treatments and TechniquesCurrent Drug Therapy 2022; 17(1): 2 doi: 10.2174/1574885517666220307115813
86
Shujuan Zhao, Xuejiao Hong, Jingjing Cao, Haixia Cai, Song Du, Peizhi Ma. Appropriate Dosing Regimens of Non-Vitamin K Antagonist Oral Anticoagulants for Treatment of Patients With Non-Valvular Atrial Fibrillation: An Evidence-Based ConsiderationFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01293
87
Sharon Wei, Aanchal Sawhney, Harshwardhan Khandait, Amit Meda, Vasu Gupta, Rohit Jain. An update on applications and limitations of direct oral anticoagulantsThe Egyptian Journal of Internal Medicine 2023; 35(1) doi: 10.1186/s43162-023-00212-5
88
So-Ryoung Lee, Hyo-Jeong Ahn, Eue-Keun Choi, Sang-Hyun Park, Kyung-Do Han, Seil Oh, Gregory Y.H. Lip. Reduction of Upper Gastrointestinal Bleeding Risk With Proton Pump Inhibitor Therapy in Asian Patients With Atrial Fibrillation Receiving Direct Oral Anticoagulant: A Nationwide Population-based Cohort StudyClinical Gastroenterology and Hepatology 2024; 22(5): 981 doi: 10.1016/j.cgh.2023.12.022
89
Pavlina Chrysafi, Kevin Barnum, Genevieve M. Gerhard, Thita Chiasakul, Arshit Narang, Megan Mcnichol, Nicoletta Riva, Georg Semmler, Bernhard Scheiner, Stefan Acosta, Pierre-Emmanuel Rautou, Mandy N. Lauw, Jonathan Berry, Walter Ageno, Jeffrey I. Zwicker, Rushad Patell. Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysisJournal of Thrombosis and Haemostasis 2024; 22(12): 3479 doi: 10.1016/j.jtha.2024.06.029
90
E. V. Moroz, A. Y. Karateev, E. V. Kryukov, A. A. Sokolov, E. N. Artemkin. Comparison of the Endoscopic Picture in Case of Complications of the upper Gastrointestinal Tract Caused by the Use of Antithrombotic Agents and Non-Steroidal Anti-Inflammatory DrugsActa Biomedica Scientifica (East Siberian Biomedical Journal) 2019; 4(5): 19 doi: 10.29413/ABS.2019-4.5.3
91
Tarek Nammour, Lara El Jamal, Mohammad N. Hosni, Hani Tamim, Anthony Kerbage, Jana G. Hashash, Yasser H. Shaib, Fady Daniel, Fadi Francis, Fadi H. Mourad, Assaad Soweid, Ala I. Sharara, Maha Makki, Don C. Rockey, Kassem Barada. Development and Validation of a Novel 1-year Mortality Risk Score That Includes the Use of Antithrombotic in Patients With Overt Gastrointestinal BleedingJournal of Clinical Gastroenterology 2023; 57(7): 700 doi: 10.1097/MCG.0000000000001736
92
Tomo Kagawa, Shigenao Ishikawa, Yu Hidaka, Hugh Shunsuke Colvin, Akira Nakanishi, Jumpei Ohkawa, Shin Negishi, Eriko Yasutomi, Kenji Yamauchi, Kunio Okamoto, Ichiro Sakakihara, Koichi Izumikawa, Kumiko Yamamoto, Sakuma Takahashi, Shigetomi Tanaka, Mihoko Matsuura, Masaki Wato, Toshimi Hasui, Tomoki Inaba. Risk factors for postgastric endoscopic submucosal dissection bleeding in direct oral anticoagulant usersDigestive Endoscopy 2024;  doi: 10.1111/den.14806
93
Gianni Turcato, Antonio Bonora, Elisabetta Zorzi, Arian Zaboli, Massimo Zannoni, Giorgio Ricci, Norbert Pfeifer, Antonio Maccagnani, Andrea Tenci. Thirty-day mortality in atrial fibrillation patients with gastrointestinal bleeding in the emergency department: differences between direct oral anticoagulant and warfarin usersInternal and Emergency Medicine 2020; 15(2): 311 doi: 10.1007/s11739-019-02229-7
94
David M. Richards, Sajini Thekkel, William A. Ross. Oncologic Critical Care2020; : 869 doi: 10.1007/978-3-319-74588-6_176
95
Yunyun Diao, Zhenzhou Zhang, Osamah Ibrahim Khalaf. Dictionary Learning-Based Ultrasound Image Combined with Gastroscope for Diagnosis of Helicobacter pylori-Caused Gastrointestinal BleedingComputational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/6598631
96
Martin Müller, Jonathan Eastline, Michael Nagler, Aristomenis K. Exadaktylos, Thomas C. Sauter. Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonistsScandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2019; 27(1) doi: 10.1186/s13049-019-0625-3
97
Nanda Kandamany, Heather Tan. Novel oral anticoagulant induced upper limb haematoma: A case reportJPRAS Open 2018; 16: 20 doi: 10.1016/j.jpra.2017.08.008
98
Yuxin Xie, Liya Zhu, Zebin Wang, Xiaojiang Zhan, Fenfen Peng, Xiaoran Feng, Qian Zhou, Xianfeng Wu, Xiaoyang Wang, Ning Su, Xingming Tang, Yujing Zhang, Yingsi Zeng, Mengmeng Li, Jianbo Liang, Lingling Liu, Yueqiang Wen. ACEi/ARBs associate with lower incidence of gastrointestinal bleeding in peritoneal dialysis patientsClinical and Experimental Nephrology 2022; 26(3): 278 doi: 10.1007/s10157-021-02150-4
99
Larisa Anghel, Radu Sascău, Anca Trifan, Ioana Mădălina Zota, Cristian Stătescu. Non-Vitamin K Antagonist Oral Anticoagulants and the Gastrointestinal Bleeding Risk in Real-World StudiesJournal of Clinical Medicine 2020; 9(5): 1398 doi: 10.3390/jcm9051398
100
Muhammad A. Shafqet, Alexander Tonthat, Paola Esparragoza, Butros Toro, Adam C. Ehrlich, Frank K. Friedenberg. Recent use of NSAID and NOAC medications are associated with a positive CT arteriogramAbdominal Radiology 2019; 44(7): 2632 doi: 10.1007/s00261-019-02005-3
101
Sampada K. Gandhi, James A. Reiffel, Rania Boiron, Mattias Wieloch. Risk of Major Bleeding in Patients With Atrial Fibrillation Taking Dronedarone in Combination With a Direct Acting Oral Anticoagulant (From a U.S. Claims Database)The American Journal of Cardiology 2021; 159: 79 doi: 10.1016/j.amjcard.2021.08.015
102
Matthew C. Dallos, Andrew B. Eisenberger, Susan E. Bates. Prevention of Venous Thromboembolism in Pancreatic Cancer: Breaking Down a Complex Clinical DilemmaThe Oncologist 2020; 25(2): 132 doi: 10.1634/theoncologist.2019-0264
103
Victoria R Nachar, Allison J Schepers. Clinical controversies in the treatment of cancer-associated venous thromboembolismJournal of Oncology Pharmacy Practice 2021; 27(4): 939 doi: 10.1177/1078155220984371
104
Ian Lancaster, Vikas Sethi, Deep Patel, Cyrus Tamboli, Elizabeth Pacer, Jeffrey Steinhoff, Meir Mizrahi, Andrew Willinger. Antithrombotics and Gastrointestinal Prophylaxis: A Systematic ReviewCardiology in Review 2024; 32(6): 528 doi: 10.1097/CRD.0000000000000543
105
Yuji Murakami, Masahiro Kenjo, Kazuki Ishikawa, Toru Sakayauchi, Satoshi Itasaka, Yoshiharu Negoro, Keiichi Jingu, Yasumasa Nishimura, Yasushi Nagata, Kazuhiko Ogawa. Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agentsJournal of Radiation Research 2020; 61(4): 629 doi: 10.1093/jrr/rraa035
106
Melina Verso, Giorgio Maraziti, Alessandra Vinci, Danilo Castellani, Gabrio Bassotti, Olivia Morelli. Clinical and endoscopic findings in patients with acute gastrointestinal bleeding associated with direct oral anticoagulants: Results from a single-center prospective cohort studyThrombosis Research 2025; 245: 109227 doi: 10.1016/j.thromres.2024.109227
107
Christoph Sucker, Jens Litmathe, Heiner K. Berthold. Orale Antikoagulation bei VorhofflimmernMMW - Fortschritte der Medizin 2019; 161(S6): 15 doi: 10.1007/s15006-019-0920-y
108
Fernando Carballo Álvarez, Agustín Albillos Martínez, Pilar Llamas Silero, Aitor Orive Calzada, Eduardo Redondo-Cerezo, Enrique Rodríguez de Santiago, Javier Crespo García. Consensus document of the Sociedad Española de Patología Digestiva on massive nonvariceal gastrointestinal bleeding and direct-acting oral anticoagulantsRevista Española de Enfermedades Digestivas 2022;  doi: 10.17235/reed.2022.8920/2022
109
Anna W. Boone, Chelsea L. Carlan, Leslie S. Lewis. Overt Small Bowel Bleeding in the Older AdultThe Journal for Nurse Practitioners 2023; 19(1): 104460 doi: 10.1016/j.nurpra.2022.09.013
110
Tatsuya Sakamoto, Tsutomu Nishida, Dai Nakamatsu, Asuka Watanabe, Takao Kitanaka, Yutaro Minoura, Kana Hosokawa, Satoru Okabe, Naohiro Sakamoto, Yoshifumi Fujii, Naoto Osugi, Aya Sugimoto, Kengo Matsumoto, Shiro Hayashi, Sachiko Nakajima, Masashi Yamamoto. Antithrombotic drug use does not affect the fecal immunochemical test PPV for colorectal cancer, but warfarin may have an impact in a Japanese cohortAsia-Pacific Journal of Clinical Oncology 2024; 20(5): 589 doi: 10.1111/ajco.13954
111
Yujing Zhou, Chunhua Liu, Yongcan Huang. Wireless Power Transfer for Implanted Medical Application: A ReviewEnergies 2020; 13(11): 2837 doi: 10.3390/en13112837
112
Stefano Ballestri, Mariano Capitelli, Maria Cristina Fontana, Dimitriy Arioli, Elisa Romagnoli, Catia Graziosi, Amedeo Lonardo, Marco Marietta, Francesco Dentali, Giorgio Cioni. Direct Oral Anticoagulants in Patients with Liver Disease in the Era of Non-Alcoholic Fatty Liver Disease Global Epidemic: A Narrative ReviewAdvances in Therapy 2020; 37(5): 1910 doi: 10.1007/s12325-020-01307-z
113
N. S. Lapina, A. A. Alekseeva, A. D. Vershinina, N. S. Khruleva, D. S. Zlobina, L. Yu. Koroleva. Gastrointestinal Bleeding in Patients with Coronary Heart Disease: Preventive OptionsKardiologiia 2020; 60(7): 125 doi: 10.18087/cardio.2020.7.n942
114
Petrica Popa, Sevastita Iordache, Dan Nicolae Florescu, Vlad Florin Iovanescu, Alexandru Vieru, Valentin Barbu, Maria-Cristina Bezna, Dragos Ovidiu Alexandru, Bogdan Silviu Ungureanu, Sergiu Marian Cazacu. Mortality Rate in Upper Gastrointestinal Bleeding Associated with Anti-Thrombotic Therapy Before and During Covid-19 PandemicJournal of Multidisciplinary Healthcare 2022; : 2679 doi: 10.2147/JMDH.S380500
115
Jean Terrier, Youssef Daali, Pierre Fontana, Chantal Csajka, Jean-Luc Reny. Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral AnticoagulantsClinical Pharmacokinetics 2019; 58(12): 1517 doi: 10.1007/s40262-019-00792-y
116
A. I. Martynov, A. A. Sheptulin, I. V. Mayev, A. N. Kazyulin, A. Ye. Karateev, A. V. Melekhov, L. K. Pal’gova, K. L. Raikhel’son. New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)Russian Journal of Gastroenterology, Hepatology, Coloproctology 2020; 30(2): 7 doi: 10.22416/1382-4376-2020-30-2-7-14
117
Martin Müller, Michaela Traschitzger, Michael Nagler, Spyridon Arampatzis, Aristomenis K. Exadaktylos, Thomas C. Sauter. Impaired kidney function at ED admission: a comparison of bleeding complications of patients with different oral anticoagulantsBMC Emergency Medicine 2021; 21(1) doi: 10.1186/s12873-021-00497-1
118
Anne-Céline Martin, Robert Benamouzig, Isabelle Gouin-Thibault, Jeannot Schmidt. Management of Gastrointestinal Bleeding and Resumption of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation: A Multidisciplinary DiscussionAmerican Journal of Cardiovascular Drugs 2023; 23(4): 407 doi: 10.1007/s40256-023-00582-9
119
Parata Chaiyana, Karjpong Techathuvanan, Supatsri Sethasine. Nonvitamin K oral anticoagulants with proton pump inhibitor cotherapy ameliorated the risk of upper gastrointestinal bleedingScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-44494-9
120
Asra Batool, Rosa T. Bui. Management of Occult GI BleedingClinical Gastroenterology 2021; : 251 doi: 10.1007/978-3-030-71468-0_15
121
Anders Holt, Jarl E. Strange, Nina Nouhravesh, Patricia McGettigan, Morten Lamberts. The ReplyThe American Journal of Medicine 2022; 135(10): e407 doi: 10.1016/j.amjmed.2022.06.008
122
Maseray S. Kamara, Choichi Sugawa. Case report: An unusual case of cecal mucosal bleedingJGH Open 2023; 7(1): 72 doi: 10.1002/jgh3.12826
123
E. V. Moroz, E. N. Artemkin, E. V. Kryukov, V. A. Chernetsov. Gastro-Intestinal Tract Complications During Antithrombotic TherapyGeneral Reanimatology 2018; 14(3): 15 doi: 10.15360/1813-9779-2018-3-15-26
124
Dorotea Bozic, Damir Alicic, Dinko Martinovic, Ivan Zaja, Josipa Bilandzic-Ivisic, Rosana Sodan, Branka Kresic, Andre Bratanic, Zeljko Puljiz, Zarko Ardalic, Josko Bozic. Plasma Drug Values of DOACs in Patients Presenting with Gastrointestinal Bleeding: A Prospective Observational StudyMedicina 2023; 59(8): 1466 doi: 10.3390/medicina59081466
125
Aktualisierte S2k-Leitlinie Helicobacter pylori und gastroduodenale Ulkuskrankheit der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Juli 2022 – AWMF-Registernummer: 021–001Zeitschrift für Gastroenterologie 2023; 61(05): 544 doi: 10.1055/a-1975-0414
126
Carmine Petruzziello, Angela Saviano, Mattia Brigida, Alessio Migneco, Luca Luigi Manetti, Marcello Candelli, Veronica Ojetti. Risk of Hemorrhoidal Bleeding in Patients Treated with Direct Oral Anticoagulants (DOACs)Gastrointestinal Disorders 2024; 6(3): 634 doi: 10.3390/gidisord6030042
127
David Richards, Sajini Thekkel, William Ross. Oncologic Critical Care2019; : 1 doi: 10.1007/978-3-319-74698-2_176-1
128
Libin Wang, Shouchang Gai, Xiaorui Zhang, Xiaohui Xu, Nan Gou, Xingchen Wang, Nan Zhou, Tian Feng. Simultaneous Determination of Rivaroxaban and TAK-438 in Rat Plasma by LC–MS/MS: Application to Pharmacokinetic Interaction StudyBioanalysis 2020; 12(1): 11 doi: 10.4155/bio-2019-0130
129
Jillie Choi, Jae Eun No, Ju-Yeun Lee, Soo An Choi, Woo-Young Chung, Young-Mi Ah, Yun Mi Yu. Efficacy and Safety of Clinically Driven Low-Dose Treatment with Direct Oral Anticoagulants in Asians with Atrial Fibrillation: a Systematic Review and Meta-analysisCardiovascular Drugs and Therapy 2022; 36(2): 333 doi: 10.1007/s10557-021-07171-5
130
Robert Benamouzig, Maxime Guenoun, David Deutsch, Laurent Fauchier. Review Article: Gastrointestinal Bleeding Risk with Direct Oral AnticoagulantsCardiovascular Drugs and Therapy 2022; 36(5): 973 doi: 10.1007/s10557-021-07211-0
131
NOAK als Sekundärprophylaxe für alle?CardioVasc 2017; 17(4): 10 doi: 10.1007/s15027-017-1202-1
132
Syeda Ayesha Shah, Hasan Mushahid, Huda Ahmed. Dabigatran for venous malformations: A call for a stringent approachJournal of Vascular Surgery: Venous and Lymphatic Disorders 2023; 11(5): 1083 doi: 10.1016/j.jvsv.2023.04.010
133
Dmitry S. Bordin, Maria A. Livzan, Olga V. Gaus, Sergei I. Mozgovoi, Angel Lanas. Drug-Associated Gastropathy: Diagnostic CriteriaDiagnostics 2023; 13(13): 2220 doi: 10.3390/diagnostics13132220
134
Gregory Y. H. Lip, Virginia Noxon, Amiee Kang, Xuemei Luo, Nipun Atreja, Stella Han, Dong Cheng, Jenny Jiang, Lisa Abramovitz, Steven Deitelzweig. Effectiveness and safety in non-valvular atrial fibrillation patients switching from warfarin to direct oral anticoagulants in US healthcare claimsJournal of Thrombosis and Thrombolysis 2024; 57(6): 1092 doi: 10.1007/s11239-024-02976-1
135
Wolfgang Fischbach, Jan Bornschein, Jörg C. Hoffmann, Sibylle Koletzko, Alexander Link, Lukas Macke, Peter Malfertheiner, Kerstin Schütte, Dieter-Michael Selgrad, Sebastian Suerbaum, Christian Schulz. Update S2k-Guideline Helicobacter pylori and gastroduodenal ulcer disease of the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS)Zeitschrift für Gastroenterologie 2024; 62(02): 261 doi: 10.1055/a-2181-2225
136
Alex Choo, Alessia Bragagnolo, Siyaguna K. D. M. Ekanayake, Alaa Alghamry. Sustained resolution of anticoagulation related iron deficiency anemia with the use of apixabanClinical Case Reports 2020; 8(1): 127 doi: 10.1002/ccr3.2585
137
Katherine A. Kelley, Karen J. Brasel. Emergency General Surgery2019; : 303 doi: 10.1007/978-3-319-96286-3_25
138
Bo Min Jang, Ok Sang Lee, Eun Jeong Shin, Eun Jeong Cho, Sung Yeon Suh, Yoon Sook Cho, Myung Koo Lee, Sandy Jeong Rhie. Factors related to inappropriate edoxaban useJournal of Clinical Pharmacy and Therapeutics 2019; 44(5): 760 doi: 10.1111/jcpt.12999